Although the mutation rate of CSNK1D is very low, a TCGA database analysis from certain tumor tissues and tumor cell lines clearly indicates genomic amplification of CSNK1D with the highest frequency in lung cancer and bladder/urinary tract cancer (Figure 2). Here, CSNK1D is linked to neoplasm.